# J&J Wins FDA Approval for Dual-Energy Ablation Catheter Targeting Atrial Fibrillation

> fda · REPORTED · 2026-07-09

Johnson & Johnson received FDA approval for its Dual Energy Thermocool Smarttouch SF Platform, a catheter delivering both radiofrequency and pulsed field energy to treat atrial fibrillation, disclosed in early July 2026. The device is integrated into J&J's Carto mapping system and is designed to help the company recapture market share lost to pulsed field ablation rivals.

About Johnson & Johnson: Johnson & Johnson MedTech is a global leader in electrophysiology devices, developing catheters and mapping systems for the treatment of cardiac arrhythmias including atrial fibrillation.

- Company: Johnson & Johnson
- Sector: medical devices
- Primary source: https://www.medtechdive.com/news/jj-wins-fda-approval-for-dual-energy-ablation-catheter/824797/

---
Source: MedFuel Intel news monitor. Verification tier: REPORTED. Informational only, not investment advice. Corrections: media@medfuelinc.com.